Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Investors 600x60px
Document › Details

DiaSorin S.p.A.. (8/3/17). "Press Relase: DiaSorin Group Reports Strong Growth in Revenues and Profitability in Q2 2017". Saluggia.

Organisations Organisation DiaSorin S.p.A. (FTSE Italia Mid Cap: DIA)
  Group DiaSorin (Group)
  Organisation 2 Siemens Healthcare GmbH (Siemens Healthineers)
  Group Siemens (Group)
Products Product Liaison analyzer
  Product 2 immunoassay (diagnostics, antibody-antigen-test)
Index term Index term DiaSorin–Qiagen: in vitro diagnostics, 201706– collab to adopt select Qiagen assays for use on Liaison platform
Persons Person Fava, Riccardo (DiaSorin 201607 IR + Corporate Communications Director)
  Person 2 Di Terlizzi, Ines (DiaSorin 201607 Investor Relations)
     


   
Record changed: 2017-08-10

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Partnering 600x60px

More documents for DiaSorin (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Investors 600x60px




» top